From: The impact of COVID-19 on gastric cancer surgery: a single-center retrospective study
Clinicopathologic data | PCG(N = 68) M (IQR) orN (%) | CG (N = 41) M (IQR) orN (%) | P |
---|---|---|---|
Pathological TNM staging | 0.394 | ||
I | 18 | 8 | |
II | 18 | 10 | |
III | 29 | 23 | |
IV | 3 | 0 | |
Complications | 0.081 | ||
Yes | 6 | 0 | |
No | 62 | 41 | |
Postoperative fever | 0.379 | ||
Yes | 29 | 14 | |
No | 39 | 27 | |
Highest temperature (°C) | 0.587 | ||
< 37.3 | 39 | 27 | |
37.3–38.5 | 22 | 12 | |
> 38.5 | 7 | 2 | |
Screening examination | 0.012* | ||
None | 16 | 2 | |
BRE + CRP | 8 | 4 | |
BRE + CRP + CT | 4 | 5 | |
Nucleic acid test | 0 | 2 | |
Reason of fever | 0.423 | ||
Abdominal infection | 1 | 0 | |
Pulmonary infection | 1 | 0 | |
Incision infection | 4 | 0 | |
Anastomotic leakage | 1 | 0 | |
Unclear | 17 | 11 | |
None | 5 | 3 | |
Transfusion of blood | 0.422 | ||
Yes | 3 | 4 | |
No | 65 | 37 | |
Postoperative hospital stay (day) | 7 (6–8) | 9 (7–11) | 0.000* |
Total hospital stay (day) | 11 (9–13) | 15 (13–19) | 0.000* |